Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Keyur Patel*, Stephen A. Harrison, Magdy Elkhashab, James F. Trotter, Robert Herring, Sergio E. Rojter, Zeid Kayali, Vincent Wai Sun Wong, Susan Greenbloom, Saumya Jayakumar, Mitchell L. Shiffman, Bradley Freilich, Eric J. Lawitz, Edward J. Gane, Eliza Harting, Jun Xu, Andrew N. Billin, Chuhan Chung, C. Stephen Djedjos, G. Mani SubramanianRobert P. Myers, Michael S. Middleton, Mary Rinella, Mazen Noureddin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

265 Scopus citations

Fingerprint

Dive into the research topics of 'Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science